African Swine Fever Virus Strain Georgia 2007/1 in

Ornithodoros erraticus Ticks
To the Editor: African swine fever virus (ASFV) causes a notifi able disease in domestic pigs for which no treatment or vaccine is available, resulting in a mortality rate of <100%. In 2007 ASFV was detected in the Caucasus region, fi rst in Georgia and subsequently in Armenia, Azerbaijan, and many parts of Russia, including regions that border other countries in Europe and Asia (1) .
Most fi eld strains of ASFV can persistently infect Ornithodoros ticks, including the species O. erraticus in southern Europe (2) , and ASFV has been isolated from ticks collected >5 years after the last confi rmed case in an outbreak (3) . These ticks can feed on alternative hosts, evade eradication attempts (such as acaricide application and fl amethrowers), and survive for up to 15 years (1 (4) or the OUR T88/1 isolate (5) as a positive control to obtain virus titers of 4 log 10 or 6 log 10 50% hemadsorbing doses (HAD 50 )/mL blood. These titers were within the observed range in naturally infected pigs (6) , and thus simulated the fi eld situation.
Ticks were fed infected blood by using a Hemotek membrane-feeding system (Discovery Workshops, Accrington, UK). Meal reservoirs were covered with stretched Parafi lm that was wiped with a thin fi lm of uninfected blood to encourage feeding. Pots of ticks were placed on the membrane and allowed to feed for 20 minutes.
Immediately after and 3, 6, 9, and 12 weeks after feeding, 10 ticks from each feeding group were killed by freezing in dry ice. After being washed with a detergent solution and phosphate-buffered saline, ticks were placed individually in tubes with 200 μL of RPMI medium (Sigma-Aldrich Company Ltd., Gillingham, UK), a 3 mm-diameter stainless steel ball (Dejay Distribution Ltd., Launceston, UK), and 1-mm silicon carbide particles (Stratech Scientifi c Ltd, Newmarket, UK). They were then homogenized by shaking for 5 cycles of 3 minutes at 25-Hz frequency using a TissueLyser (QIAGEN, Valencia, CA, USA). To complete a 1-mL volume, 800 μL of RPMI medium was added to the tubes after centrifuging 2× for 30 seconds at 2,000 rpm. Supernatants were transferred to fresh tubes and centrifuged for 5 minutes at 1,000 × g.
Virus titers were estimated on porcine bone marrow cells (7) and expressed as log 10 HAD 50 per tick. Previous studies suggest that it takes 3-4 weeks for ticks to completely digest and clear ingested blood and that virus isolated after this period is due to viral replication (5, 6) . A general linear model, fi tted via maximum likelihood, was used to assess the effects of isolate, dose, time after feeding, and interaction between isolate and time after feeding on the viral titer in the tick. Confi dence intervals were calculated by profi le likelihood.
Results showed that the Georgia 2007/1 strain can replicate in the O. erraticus tick. We recovered virus titers of <1.8 to >9.8 log 10 HAD 50 per tick. Ticks that fed on blood containing 6 log 10 HAD 50 ASFV on average had virus titers 2.15 log 10 HAD 50 higher than those for ticks that fed on blood containing 4 log 10 HAD 50 /mL. Over time, the average titer for both isolates increased at an estimated rate of 0.65 log 10 HAD 50 /week, indicating replication. Statistical analysis suggested that immediately after feeding, ticks fed on the Georgia 2007/1 strain contained 1.36 log 10 HAD 50 less virus than those fed on the OUR T88/1 isolate, but we detected no statistically signifi cant difference in the replication rates of the 2 isolates. Parameter estimates are shown in the Table and the model fi t is shown in the Figure. The whole-tick titers reported in this study are consistent with those from previous studies (5,6). However, >9 weeks after the ticks fed, we observed higher titers than those reported (5), and many results showed >9.8 log 10 HAD 50 per tick. The TissueLyser may have been more effective at releasing ASFV from tick tissues than previously used methods. Our results suggest that virus replication within the ticks began by 3 weeks after feeding on infected blood; this timing is consistent with that in previous studies (5, 8, 9) .
We observed high viral titers for >12 weeks after infection. Previous studies showed that ASFV can persist at high titers for 20 weeks after infection (10) . We demonstrated that ASFV Georgia 2007/1 isolate can replicate effi ciently in ticks. This fi nding highlights the importance of clarifying the distribution of Ornithodoros species ticks in the Russian Federation and Caucasus region and the relationship of these ticks to species susceptible to ASFV.
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The patient, who spontaneously had become asymptomatic shortly after seeking care, was treated unsuccessfully with the benzimidazole derivative triclabendazole (TCBZ) on 3 separate occasions during the next 2 years. He was fi rst treated with a single dose of 10 mg/kg TCBZ (Fasinex suspension; Novartis Animal Health Ltd., Surrey, UK), then with 2 doses 24 hours apart, and on the last occasion with 2 doses of TCBZ (Egaten; Sipharm Sisseln AG, Sisseln, Switzerland) 10 mg/kg 12 hours apart; the last 4 treatments were taken with food. Feces remained positive for F. hepatica eggs after each treatment. IgG titers remained positive (320, by enzyme immunoassay), and fl ukes could be visualized by ultrasound in the gallbladder and common bile duct (Figure) . Thereafter, the patient was treated with nitazoxanide (500 mg 2×/d for 7 days); however, fecal samples remained positive for F. hepatica eggs. Lastly, after recent experiments of a combination therapy in a rat model (1), we treated the patient with TCBZ (Egaten, 10 mg/ kg) combined with ketoconazol 10 mg/kg taken with food. Still, his feces remained positive for F. hepatica eggs.
Fascioliasis is a zoonotic disease caused by the foodborne trematode F. hepatica or F. gigantica, which has a complex life cycle and mainly affects sheep and cattle (2) . Eggs of the adult worms (2-4 cm) that live in the bile ducts of the fi nal host are excreted in the feces and develop into larvae (miracidia) in water. The miracidia then penetrate, and further develop in, snails of the family Lymnaeidae. Freeswimming cercariae exit the snail and attach to aquatic vegetation, where they encyst as metacercariae. After
